1. The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
   Xin Jin et al, 2022, Disease Markers CrossRef
2. Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
   Zhenjun Yu et al, 2021, Frontiers in Oncology CrossRef
3. Cell division cycle associated 2 (CDCA2) upregulation promotes the progression of hepatocellular carcinoma in a p53-dependant manner
   Jiahui Wang et al, 2022, PeerJ CrossRef
4. Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints
   Mengying Tang et al, 2022, Frontiers in Medicine CrossRef